Cardinal Health, Inc. (CAH)
NYSE · Healthcare · Medical Distribution
$233.12+2.11%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $54.0B
- P/E (trailing)
- 32.2
- Forward P/E
- 16.6
- Dividend yield
- 0.9%
- 52-week range
- $151.87 – $258.30
- 52-week change
- +45.74%
- EPS (trailing)
- $7.23
- Analyst rating
- 1.5 Strong buy
- Next earnings
- Nov 5, 2026
Fiscal year to Jun 2026
- Revenue
- $254B (+14.23%)
- Net income
- $1.7B
- Operating margin
- 1.0%
- Diluted EPS
- $7.23
- Free cash flow
- $4.5B
From the company’s annual report on SEC EDGAR.
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products.
Headquarters: Dublin, United States · 58,788 employees · cardinalhealth.com